Öven Elif Naz, Genc Asena Ayse, Erk Nevin, Ahmed Hassan Elzain Hassan, Soylak Mustafa
Department of Analytical Chemistry, Faculty of Pharmacy, Ankara University, 06560, Ankara, Turkey.
The Graduate School of the Health Sciences, Ankara University, 06110, Ankara, Turkey.
Mikrochim Acta. 2025 Aug 26;192(9):624. doi: 10.1007/s00604-025-07476-4.
A novel electrochemical sensor based on a glassy carbon electrode (GCE) modified with a NiCaAl layered double hydroxide with carboxyl-functionalized nanodiamonds (NiCaAl-LDH@ND-COOH) was developed for the first time to enable sensitive and selective detection of larotrectinib (LARO), the first selective pan-tropomyosin receptor kinase (TRK) inhibitor used clinically for cancer treatment. The nanocomposite was synthesized by integrating NiCaAl layered double hydroxide (LDH) with carboxyl-functionalized nanodiamonds (ND-COOH), resulting in enhanced electrocatalytic performance. The individual electrochemical properties of ND-COOH and NiCaAl-LDH were systematically evaluated and compared with those of the combined nanocomposite. ND-COOH contributed high surface area, low background current, and improved conductivity, while NiCaAl-LDH offered abundant redox-active sites and high ion-exchange capacity. The NiCaAl-LDH@ND-COOH nanocomposite exhibited a synergistic enhancement in electron transfer kinetics and surface activity, as evidenced by cyclic voltammetry and impedance studies. Under optimized conditions, the sensor displayed a wide linear detection range (1.0 to 16.37 µM) and a low detection limit of 4.36 nM. It also demonstrated excellent repeatability (RSD = 1.3%), reproducibility (RSD = 1.23%), and high selectivity against common interferents. Successful application to pharmaceutical formulations, serum, and urine samples confirmed its practicality, achieving recoveries between 96.7% and 102.6%. This work provides the first electrochemical sensing platform for LARO, offering a reliable and cost-effective tool for its monitoring in clinical and pharmaceutical settings.
首次开发了一种基于修饰有羧基官能化纳米金刚石的镍钙铝层状双氢氧化物(NiCaAl-LDH@ND-COOH)的玻碳电极(GCE)的新型电化学传感器,用于灵敏且选择性地检测拉罗替尼(LARO),这是临床上用于癌症治疗的首个选择性泛原肌球蛋白受体激酶(TRK)抑制剂。通过将镍钙铝层状双氢氧化物(LDH)与羧基官能化纳米金刚石(ND-COOH)整合来合成纳米复合材料,从而提高了电催化性能。系统评估并比较了ND-COOH和NiCaAl-LDH的各自电化学性质以及复合纳米复合材料的电化学性质。ND-COOH具有高表面积、低背景电流和改善的导电性,而NiCaAl-LDH提供了丰富的氧化还原活性位点和高离子交换容量。循环伏安法和阻抗研究证明,NiCaAl-LDH@ND-COOH纳米复合材料在电子转移动力学和表面活性方面表现出协同增强作用。在优化条件下,该传感器显示出宽线性检测范围(1.0至16.37 µM)和4.36 nM的低检测限。它还表现出出色的重复性(RSD = 1.3%)、再现性(RSD = 1.23%)以及对常见干扰物的高选择性。在药物制剂、血清和尿液样本中的成功应用证实了其实用性,回收率在96.7%至102.6%之间。这项工作为拉罗替尼提供了首个电化学传感平台,为其在临床和制药环境中的监测提供了一种可靠且经济高效的工具。